ACAntonina I. Chertkova

Antonina I. Chertkova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antonina I. Chertkova has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immune profiles of peripheral blood and tumor tissue in molecular subtypes of breast cancer: correlation with soluble forms of programmed cell death-1 receptor and its ligand

    by Sergey S. Salamatin, Саламатин Сергей Сергеевич, Anna A. Borunova, Борунова А. А., Dmitry V. Rogozhin, Рогожин Д. В., Antonina I. Chertkova, Черткова А. И., Zaira G. Kadagidze, Кадагидзе З. Г., et al.

    Background. Molecular subtypes of breast cancer determine not only the biological behavior of the tumor, but also the nature of the antitumor immune response. However, the connection between T-lymphocyte subpopulations and the soluble forms of the programmed cell death 1 receptor (sPD-1) and its ligand (sPD-L1) is not well studied. Aim. To study the relationship of sPD-1 / sPD-L1 levels with the functional state of peripheral blood T-lymphocytes and the tumor microenvironment in various molecular subtypes of breast cancer. Materials and methods. The study included 63 patients with luminal B (HER2–) (HER2 – human epidermal growth factor receptor 2), luminal B (HER2+), non-luminal (HER2+), and triple negative breast cancer. Lymphocyte subpopulations were analyzed by flow cytometry and sPD-1 / sPD-L1 levels were determined by enzyme immunoassay. Results. In triple negative cancer, a profile of functionally competent cytotoxic T-lymphocytes was revealed with a strong negative correlation between the level of sPD-L1 and the proportion of CD8+perforin+ tumor-infiltrating lymphocytes (r = –0.975; p = 0.005). Luminal subtype B (HER2–) is characterized by signs of T cell depletion and a “cold” immune phenotype. Conclusion. Soluble forms of PD-1 / PD-L1 demonstrate subtype-specific correlations with the functional state of T-lymphocytes, which indicates their potential as prognostic biomarkers, especially in triple negative breast cancer.

  • Open Access

    Prognostic value of interleukins 6 and 8 in assessing the effectiveness of therapy in patients with triple-negative breast cancer

    by Antonina I. Chertkova, Ilona B. Shoua, Anna A. Borunova, Zaira G. Kadagidze, Sergey L. Gutorov, Tatiana N. Zabotina

    Background. Interleukin (IL) 6 is a potent proinflammatory pleiotropic cytokine and is a key factor in the immune escape of malignant cells. IL-8 (or CXCL8) is a proinflammatory chemokine, high levels of expression of which were observed in various types of cancer. Aim. To determine the relationship between the level of IL-6 and IL-8 cytokines in the blood serum with the main populations of peripheral blood lymphocytes and its significance for the results of neoadjuvant chemotherapy for triple-negative breast cancer (TN BC). Materials and methods. All 64 patients received chemotherapy and surgery. The concentrations of IL-6 and IL-8 (ng/ml) in the blood serum and the percentage of the main lymphocyte populations in the peripheral blood (PB) were determined. Results. The relationship between progression, metastasis and death of patients with higher IL-6 concentrations in the blood serum of patients with TN BC was demonstrated. Before treatment, a positive correlation was found between the IL-6 level and the percentage of HLA-DR, CD3+HLA-DR+, CD3–HLA-DR+ lymphocytes, which, as previously shown, are negative prognostic factors in TN BC. An increase in the IL-6 level was combined with a decrease in the percentage of CD4+ T lymphocytes. Conclusion. The obtained results are consistent with the position that IL-6 is a negative prognostic factor in patients with BC. The positive relationship between IL-6 and “negative” HLA-DR, CD3+HLA-DR+, CD3‒HLA-DR+ lymphocyte populations found in the work indicates their interaction in stimulating tumor growth.

  • Open Access

    Regulatory B cells: role in the immune response to tumor

    by Z.G. Kadagidze, A.I. Chertkova, A.A. Borunova, T.N. Zabotina

    Регуляторные B-клетки: роль в иммунном ответе на опухоль

  • Open Access

    The two types of immune microenvironment of renal cancer

    by A. A. Borunova, A. A. Alimov, I. B. Shoua, A. I. Chertkova, Z. G. Kadagidze, A. Yu. Kuzevanova, N. K. Zhumabaev, F. M. Abdul, O. A. Khalmurzaev, K. S. Nemtseva, et al.

    Background. The tumor microenvironment can both restrain tumor growth and promote disease progression. Therefore, the study of tumor-infiltrating lymphocytes (TILs) subpopulation composition is an urgent and significant topic.Aim. To characterize the immune microenvironment of renal cancer by flow cytometry.Materials and methods. The study included blood, kidney tumor and normal tissue of the removed kidney of 32 patients with clear cell renal cancer treated at N. N. Blokhin National Medical Research Center of Oncology. Kidney tissue was obtained during surgical removal of the tumor (resection / nephrectomy). A fragment of tumor and normal tissue was taken for analysis under the control of a morphologist. Blood for the study was taken on the day of surgery. Immunologic study was performed by flow cytometry. Kidney tissue was preliminarily homogenized and cell suspension was stained, as well as peripheral blood, with monoclonal antibodies to CD45, CD3, CD4, CD8, CD16+CD56+, CD19, CD28, CD279, CD11b labeled with different fluorochromes.Results. T-lymphocytes and natural killer (NK) cells have a pronounced inverse correlation, which allowed us to distinguish two (n = 32; 18 / 14) variants of tumor immune microenvironment. T-cell variant, with predominance of CD3+CD8+ cells over CD3+CD4+ lymphocytes, and NK cell variant – increase in the number of NK cells with a pronounced decrease in the proportion of T-lymphocytes at the expense of CD3+CD8+ lymphocytes. The two variants are based on the difference of effector link – predominance of cells of innate (NK) or adoptive (CD3+CD8+) immunity. TILs immune profiles also differed in the number of CD8+PD1+ cells – in the T-cell variant their number was 2 times higher than in the NK cell variant. The similar distribution concerned CD4+ Treg cells.Conclusion. Two immunologically competitive variants of renal tumor microenvironment were revealed – T-cell variant, characterized by a greater degree of infiltration and concentration of T-regulatory cells; NK cell variant, with an insignificant degree of infiltration and a pronounced strengthening of the effector link in the tissue and proinflammatory activity of peripheral blood.

  • Open Access

    Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study

    by Tatiana N. Zabotina, Antonina I. Chertkova, Anna A. Borunova, Nikolay E. Kushlinskii, Elena S. Gershtein, Elena N. Zakharova, Esma K. Shoua, Vasily T. Tsiklauri, Igor V. Samoylenko, Maxim V. Khoroshilov, et al.

    Background. The PD-1/PD-L1 pathway plays an important role in tumor evasion from immunological surveillance. In addition to the membrane forms of PD-1 and PD-L1, there are soluble variants: sPD-1 and sPD-L1. Both membrane and soluble forms have immunoregulatory properties and can affect the function and number of different immune cell populations. Aim. To study the relationship between the initial level of CD8⁺PD-1⁺ and CD4+PD-1⁺ lymphocytes and soluble forms of sPD-1 and sPD-L1 with the percentage of the main effector and regulatory populations of peripheral blood (PB) lymphocytes and tumor-infiltrating lymphocytes. Materials and methods. The study included melanoma, breast cancer and the oral mucosa cancer patients. The percentage of cell populations of PB lymphocytes and tumor-infiltrating lymphocytes was determined by flow cytometry before treatment. The concentrations of sPD-1 and sPD-L1 proteins were studied in blood serum using enzyme immunoassay. Results. The relationship of the level of CD8⁺PD-1⁺ cells with certain populations of CD8-lymphocytes in PB and tumor tissue was found. In the PB of melanoma patients with CD8⁺CD11b⁺CD28⁺ and CD8⁺CD11b⁻CD28⁻ T cells, in breast cancer patients with a population of CD8⁺CD11b⁺CD28⁺ lymphocytes. In the tumor tissue of all patients there was a positive correlation with a population of regulatory CD8⁺CD11b⁻CD28⁻ T cells. The immunoregulatory properties of sPD-1 and sPD-L1 were confirmed. Both sPD-1 and sPD-L1 levels were positively correlated with the number of suppressor CD8⁺CD11b⁻CD28⁻ T cells and negatively with the level of CD8 lymphocytes, CD8⁺CD11b⁺CD28⁺ cytotoxic/memory T cells, B cells and activated CD25 lymphocytes. Conclusion. The results of the study can make a certain contribution to the study of the prognostic significance of membrane and soluble forms of PD-1 and PD-L1, taking into account the peculiarities of their relationship with suppressor and effector populations of lymphocytes of systemic and local immunity.


  • Open Access

    Features of cell immunity of healthcare workers in the first wave of the SARS-CoV-2 infection pandemic

    by A.A. Borunova, E.K. Shoua, E.N. Zakharova, A.I. Chertkova, Z.G. Kadagidze, I.B. Shoua, T.V. Davydova, N.E. Kushlinskii, I.V. Babkina, N.G. Osipova, et al.

    Особенности клеточного иммунитета медицинских работников в первую волну пандемии SARS-CoV-2-инфекции


  • Open Access

    Influence of gender and age of patients with oral mucosa cancer on the phenotype of systemic and local immunity

    by T. N. Zabotina, A. I. Chertkova, A. A. Borunova, E. N. Zakharova, E. K. Shoua, I. B. Shoua, V. T. Tsiklauri, I. A. Zaderenko, Z. G. Kadagidze

    Background. The incidence of oral mucosa cancer (OMC) is higher in people over 50 years of age, and the aggressiveness of the course of the disease is higher in people under 50 years of age. In this context, it is of interest to clarify the mechanisms of immune disorders characteristic of patients of different age groups.Aim. To research systemic and local immunity in OMC patients and the relationship of peripheral blood lymphocyte population (PBLs) and tumor infiltrating lymphocytes (TILs) with the patient’s sex and age.Materials and methods. PBLs and TILs effector and suppressor populations were studied by flow cytometry in OMC patients aged 29 to 84 years.Results. The percentage of CD3-, CD3+CD4+ and CD3+CD8+T cells, regulatory CD4+CD25+CD127low/ –(CD4Treg) and CD8+CD11b–CD28–(CD8Тreg) T lymphocytes, CD4+PD-1+ and CD8+PD-1+ T cells was increased in TILs compared to PBLs. The levels of cytotoxic CD8+CD11b+CD28– T lymphocytes, NK, CD8+Perforin+ and CD16+Perforin+ cells in TILs were lower than in PBLs. The relationship between the level of CD4Treg and other TILs and PBLs depended on the patient’s sex. Age-related changes in the levels of NK and CD8 T-cells were observed in men, and CD4Treg – in women.Conclusion. Local immunity in OMC patients is highly immunosuppressive. The sex of patients influences the relationship between CD4Treg and other populations of PBLs and TILs, as well as age-related changes in the OMC patients’ immune system. This investigation results can make a certain contribution to personalized treatment of patients with OMC, taking into account differences in systemic and local immunity and in the immune response to the tumor in patients of different sex and age.

  • Open Access

    RELATIONSHIP OF LYMPHOCYTE SUBPOPULATIONS IN BREAST CANCER PATIENTS WITH TREATMENT RESULTS

    by T. N. Zabotina, A. I. Chertkova, A. A. Borunova, E. N. Zakharova, E. K. Shoua, E. V. Artamonova, E. I. Kovalenko, M. V. Horoshilov, A. G. Kadagidze

    Introduction. Breast cancer (BC) is an immunogenic tumor. Immune cells infiltration of tumor tissue can affect the clinical course of the disease. The immunogenicity of breast cancer varies depending on the molecular subtype.The aim of this work was to study the main indicators of systemic and local immunity before patient’s treatment and to determine their relationship with the immediate neoadjuvant chemotherapy results.Materials and methods. Patients with stage II–III BC received standard neoadjuvant chemotherapy in accordance with the molecular subtypes. The percentage of the main effector and regulatory lymphocytes populations of systemic and local immunity was determined by flow cytometry.Results. A decrease in the level of effector CD8 and CD4 lymphocyte populations and an increase in the level suppressor populations in tumor tissue in comparison with peripheral blood indicate an immunosuppressive state of local immunity in BC patients. In tumor tissue, a high level of CD8+ PD-1+ and CD4+ PD-1+ cells were associated with a high level of regulatory CD4+ CD25highCD127–/low and CD8+ CD11b– CD28– lymphocytes. Differences were found in the significance of individual lymphocyte populations for the immediate results of treatment between patients with different subtypes of breast cancer.Conclusion. Determination of lymphocyte subpopulations correlating with the level of PD-1 cells, and the results of treatment in patients with different molecular BC subtypes, will help a clearer understanding of the antitumor immune response in this pathology, and will also serve as a basis for identifying immune biomarkers that can be used as additional predictive factors in various treatment options for BC patients.


  • The relationship of markers of early and late lymphocytes activation with the efficiency of neoadjuvant chemotherapy in triple negative breast cancer patients

    by Z.G. Kadagidze, N.N. Blokhin National Medical Research Center of Oncology» of Ministry of Health of the Russian Federation, A.I. Chertkova, T.N. Zabotina, O.O. Gordeeva, A.A. Borunova, E.K. Shoua, E.N. Zakharova, D.V. Tabakov


  • Open Access

    ASSOCIATION OF NKT- AND ACTIVATED CD25+ PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS

    by A. I. Chertkova, E. G. Slavina, T. N. Zabotina, Z. G. Kadagidze, E. K. Shoua, O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Gan’sHina, A. A. Meshcheryakov

    Background. We previously found that a decrease in the number of NKT cells and activated CD 25+ peripheral blood lymphocytes (PBLs) before neoadjuvant chemotherapy was associated with an increased likelihood of disease progression in patients with locally advanced triple-negative breast cancer (TN BC).The purpose of this study was to determine the relationship between the initial number of NKT-and CD 25+ PBLs and relapsefree survival (RFS)/overall survival (OS ) in patients with TN BC who received neoadjuvant chemotherapy with cisplatin and paclitaxel followed by surgery.Material and Methods. The study included patients with stage II and III TN BC. The follow-up time was 36 and 66.9 months. Immediately before chemotherapy, the percentage of CD 3+CD 16+CD 56+ (NKT) -, CD 25+- and CD 8+ PBLs was determined by flow cytometry. Statistical analysis of the data was carried out using the Statistics 7 software package. The Kaplan-Meier method was used to determine the relationship between immunological parameters and RFS/ OS .Results. The decreased level of NKT cells before treatment was associated with a decrease in the 3-year RFS [Me: 20.1 (0.533 and 39.7) months] compared to that observed in patients with higher percentage of these cells than in the control (Me was not achieved). There were no statistically significant differences in the 3-year OS between the groups. The initially reduced number of CD 25+ lymphocytes in comparison with the control was associated with decreased rates of both RFS and OS . The difference in DFS and OS was more significant between the groups of patients who simultaneously had an increased initial number of both NKT and CD 25+ cells and patients in whom both cell populations were below normal levels.Conclusion. The initial (prior to chemotherapy) number of NKT and activated CD 25+ PBLs can apparently be a predictive factor in TN BC patients, who received neoadjuvant chemotherapy with cisplatin and paclitaxel.